HIV-1 expression induces cyclin D1 expression and pRbphosphorylation in infected podocytes: Cell-cycle mechanisms contributing totheproliferative phenotype in HIV-associated nephropathy

BMC Microbiology

Volumn 2, Issue , 2002, Pages 1-8

  Nelson, Peter J ^a   Sunamoto, Masaaki ^a   Husain, Mohammad ^a   Gelman, Irwin H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; FLAVOPIRIDOL; MESSENGER RNA; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CONTACT; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERPLASIA; KIDNEY CELL CULTURE; KIDNEY DISEASE; KIDNEY TUBULE EPITHELIUM; MOUSE; NEPHRON; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; VIRUS EXPRESSION; VIRUS PATHOGENESIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS MUSCULUS;

EID: 34248395109     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-2-26     Document Type: Article

References (35)

1. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C: Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001, 20:146-55
2. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G: Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 1998, 339:1093-9
3. Janoff EN, Smith PD: Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology 2001, 120:607-21
4. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE: Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000, 58:674-83
5. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 2000, 58:137-43
6. Schwartz EJ, Cara A, Snoeck H, Ross MD, Sunamoto M, Reiser J, et al: Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J Am Soc Nephrol 2001, 12:1677-84
7. Nelson PJ, Gelman IH, Klotman PE: Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes. J Am Soc Nephrol 2001, 12:2827-31
8. Husain M, Gusella GL, Klotman ME, Gelman IH, Ross MD, Schwartz EJ, et al: HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes. J Am Soc Nephrol 2002, 13:1806-15
9. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999, 10:51-61
10. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 2000, 58:173-81
11. Dickie P, Felser J, Eckhaus M, Bryant J, Silver J, Marinos N, et al: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 1991, 185:109-19
12. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, et al: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A 1992, 89:1577-81
13. Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997, 100:84-92
14. Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, et al: An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci U S A 2001, 98:9271-6
15. Frankel AD, Young JA: HIV-1: fifteen proteins and an RNA. Annu Rev Biochem 1998, 67:1-25
16. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, et al: DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994, 125:625-38
17. Ojala PM, Yamamoto K, Castanos-Velez E, Biberfeld P, Korsmeyer SJ, Makela TP: The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol 2000, 2:819-25
18. Santoni-Rugiu E, Falck J, Mailand N, Bartek J, Lukas J: Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol Cell Biol 2000, 20:3497-509
19. Frame MC, Fincham VJ, Carragher NO, Wyke JA: v-Src's hold over actin and cell adhesions. Nat Rev Mol Cell Biol 2002, 3:233-45
20. Ekholm SV, Reed SI: Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000, 12:676-84
21. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993, 7:812-21
22. Park SK, Kim W, Lee H, Lee DY, Koh GY: Differential changes of cell cycle regulators and activities in kidneys during pre- and postnatal development. Nephron 1999, 81:334-41
23. Shankland SJ, Wolf G: Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000, 278:F515-29
24. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, et al: The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. Embo J 1996, 15:7060-9
25. Nelson PJ, Daniel TO: Emerging targets: Molecular mechanisms of cell contact-mediated growth control. Kidney Int 2002, 61(Suppl 1):99-105
26. Pabst R, Sterzel RB: Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 1983, 24:626-31
27. Reiser J, Kriz W, Kretzler M, Mundel P: The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000, 11:1-8
28. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, Kriz W, et al: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997, 236:248-58
29. Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, et al: Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 2000, 275:28345-8
30. Chao SH, Price DH: Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem 2001, 276:31793-9
31. Hanna Z, Weng X, Kay DG, Poudrier J, Lowell C, Jolicoeur P: The pathogenicity of human immunodeficiency virus (hiv) type 1 nef in cd4c/hiv transgenic mice is abolished by mutation of its sh3-binding domain, and disease development is delayed in the absence of hck. J Virol 2001, 75:9378-92
32. Penuel E, Martin GS: Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell 1999, 10:1693-703
33. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N: Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 1998, 273:29864-72
34. Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivieres S, Mercep L, Ferrari S: Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 1998, 273:14424-9
35. Ray PE, Bruggeman LA, Weeks BS, Kopp JB, Bryant JL, Owens JW, Notkins AL, Klotman PE: bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int 1994, 46:759-72